DataMeds AI Statistics
Want to see MEDS full AI Analyst Report?
DataMeds AI (MEDS) Stock Statistics & Valuation Metrics
Total Valuation
DataMeds AI has a market cap or net worth of $3.91M. The enterprise value is $38.31M.
- Market Cap
- $3.91M
- Enterprise Value
- $38.31M
Share Statistics
DataMeds AI has 4,515,862 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,515,862
- Owned by Insiders
- 11.96%
- Owned by Institutions
- 0.76%
Financial Efficiency
DataMeds AI’s return on equity (ROE) is 8.14 and return on invested capital (ROIC) is -659.05%.
- Return on Equity (ROE)
- 8.14
- Return on Assets (ROA)
- -3.32
- Return on Invested Capital (ROIC)
- -659.05%
- Return on Capital Employed (ROCE)
- -119.52
- Revenue Per Employee
- 752.83K
- Profits Per Employee
- -3.27M
- Employee Count
- 31
- Asset Turnover
- 0.77
- Inventory Turnover
- 20.11
Valuation Ratios
The current PE Ratio of DataMeds AI is -0.04. DataMeds AI’s PEG ratio is -0.00.
- PE Ratio
- -0.04
- PS Ratio
- 0.44
- PB Ratio
- -1.41
- Price to FCF
- -0.23
- Price to Operating Cash Flow
- -0.17
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, DataMeds AI had revenue of 23.34M and earned -101.27M in profits. Earnings per share was -71.50.
- Revenue
- 23.34M
- Gross Profit
- -9.64M
- Operating Income
- -81.19M
- Pretax Income
- -101.27M
- Net Income
- -101.27M
- EBITDA
- -93.48M
- Earnings Per Share (EPS)
- -71.50
Cash Flow
In the last 12 months, operating cash flow was -15.50M and capital expenditures -255,382, giving a free cash flow of -15.76M billion.
- Operating Cash Flow
- -15.50M
- Free Cash Flow
- -15.76M
- Free Cash Flow per Share
- -4.56
Dividends & Yields
DataMeds AI pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -437.42%
- Earnings Yield
- -4609.05%
Stock Price Statistics
- Beta
- 0.17
- 52-Week Price Change
- -97.30%
- 50-Day Moving Average
- 2.48
- 200-Day Moving Average
- 4.81
- Relative Strength Index (RSI)
- 26.26
- Average Volume (3m)
- 6.61M
Important Dates
DataMeds AI upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- Nov 13, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
DataMeds AI as a current ratio of 0.09, with Debt / Equity ratio of -198.97%
- Current Ratio
- 0.09
- Quick Ratio
- 0.04
- Debt to Market Cap
- 0.85
- Net Debt to EBITDA
- -0.26
- Interest Coverage Ratio
- -17.73
Taxes
In the past 12 months, DataMeds AI has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
DataMeds AI EV to EBITDA ratio is -0.59, with an EV/FCF ratio of -2.29.
- EV to Sales
- 4.18
- EV to EBITDA
- -0.59
- EV to Free Cash Flow
- -2.29
- EV to Operating Cash Flow
- -2.44
Balance Sheet
DataMeds AI has $476.60K in cash and marketable securities with $19.84M in debt, giving a net cash position of -$19.37M billion.
- Cash & Marketable Securities
- $476.60K
- Total Debt
- $19.84M
- Net Cash
- -$19.37M
- Net Cash Per Share
- -$4.29
- Tangible Book Value Per Share
- -$8.98
Margins
Gross margin is -128.09%, with operating margin of -384.58%, and net profit margin of -564.77%.
- Gross Margin
- -128.09%
- Operating Margin
- -384.58%
- Pretax Margin
- -565.48%
- Net Profit Margin
- -564.77%
- EBITDA Margin
- -204.20%
- EBIT Margin
- -336.46%
Analyst Forecast
The average price target for DataMeds AI is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -78.16%
- EPS Growth Forecast
- -15.07%
Scores
- Smart Score
- ―
- AI Score
- 43
